Hyponatremia overview

Jump to navigation Jump to search

Hyponatremia Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hyponatremia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiogram or Ultarsound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hyponatremia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hyponatremia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hyponatremia overview

CDC on Hyponatremia overview

Hyponatremia overview in the news

Blogs on Hyponatremia overview

Directions to Hospitals Treating hyponatremia

Risk calculators and risk factors for Hyponatremia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Saeedeh Kowsarnia M.D.[2]

Overview

The hyponatrmeia registry gives a quantitative overview of the diagnosis and treatment of hyponatremia[1].

Historical Perspective

In 1858, Claude Bernard, French physiologist first proposed a direct relationship between the central nervous system and renal excretion of osmotically active solutes. In 1913, Jungmann and Meyer in Germany induced polyuria and increased urinary salt excretion in animals through medullary lesion. In 1950, Peters, Welt, and co-workers described few patients with encephalitishypertensive intracranial hemorrhage, and bulbar poliomyelitis who presented with severe dehydration and hyponatremia.

Classification

Hyponatremia (serum sodium less than 135 mEq/L) may be classified based upon serum ADH level, duration of hyponatremia, serum osmolality and volume status. The various classification systems enable accurate identification of the cause of hyponatremia and hence translate into optimal management based on the condition of the patient.

Pathophysiology

Hyponatremia is defined as serum sodium less than 135 mEq/L (mmol/L). Sodium is the major electrolyte which determines serum osmolality. Hyponatremia is a water balance disorder in which the ratio between sodium and water is disturbed. Water homeostasis is regulated mainly by two organs: hypothalamus by ADH secretion and thirst, kidney by water reabsorption or excretion. ADH is secreted due to alteration in serum osmolality or intravascular volume. Mechanisms in which different disorders cause hyponatremia involve ADH (secretion or action) and kidney function ( absorption or excretion). ADH secretion is increased by increased osmolality of serum or decreased effective intravascular volume.

Causes

Hyponatremia is caused by either increase ADH action/ secretion or kidney function impairment. SIAD is the most common cause of euvolemic hyponatremia. After SIAD, polydipsia, drugs and clinical disorders are the most encountered etiologies in clinical practice.

Differentiating Hyponatremia

Different disorders which cause hyponatremia are differentiated based on volume status, clinical presentation, serum and urine osmolality.

Epidemiology and Demographics

Hyponatremia is the most common electrolyte disorder. Its frequency is higher in females, elderly, and the patients who are hospitalized. The incidence of hyponatremia depends largely on the patient population which is a dependent on the underlying cause. A hospital incidence of 15–30% is common. Age over 30, female gender and lower body weights are risk factors for developing complications associated with hyponatremia.

Risk Factors

Hyponatremia, the most common electrolyte abnormality, is more common in patients with chronic underlying diseases. Certain drugs, low body weight and previous history of hyponatremia are the most prominent risk factors for developing hyponatremia.

Screening

Hyponatremia is the most common electrolyte disturbances which are common with certain medical conditions and drugs. Screening the hyponatremia is necessary for preventing further decrease in serum sodium and complications of treatment.

Natural History, Complications, and Prognosis

Brain adaptive mechanisms to hyponatremia are developed over hours. Shifting of water to brain cells causes brain edema and increased intracranial pressure. Excretion of osmole from brain cells decreases osmotic gradient and brain edema. Impairment of adaptive mechanisms and acute onset of hyponatremia cause encephalopathy and brain herniation. Rapid treatment of hyponatremia will not allow adaptive mechanisms to develop and may cause in osmotic demyelination syndrome, also called central pontine demyelination.


Diagnosis

Diagnostic study of choice

Best diagnostic test to measure hyponatremia, serum sodium < 135 mEq/L, is direction-specific electrode potentiometry. Other tests are associated with false results in certain conditions. Different etiologies of hyponatremia are differentiated based on serum osmolality, urine osmolality, and urine sodium.

History and Symptoms

Symptoms associated with hyponatremia are caused mostly by impairment of brain function. There is a spectrum of signs from no detectable presentation to death. To evaluate the causes of hyponatremia, careful history has to be taken. Drug history and past medical history can lead to the most common causes of hyponatremia.

Physical Examination

Hyponatremia by itself has the signs of CNS function impairment and the other signs which can be detected in the physical exam are caused by the etiologies of hyponatremia. Depending on the severity of hyponatremia, signs vary from subtle cognitive impairment to brain death. Patients who present with hyponatremia, depending on the underlying causes, may present with different signs in clinical evaluation.

Laboratory Findings

In hyponatremia, depending on the causes, different laboratory abnormalities can be found. Check for

The unnamed parameter 2= is no longer supported. Please see the documentation for {{columns-list}}.
2

Electrocardiogram

X-ray

Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Hyponatremia, serum sodium < 135 mEq/L, is the most common electrolyte disturbances in the clinical encounter. Treatment of hyponatremia based on the etiologies is the best approach because in most cases, hyponatremia resolves with the treatment of underlying causes. The rate of correction for hyponatremia is very important to prevent the syndrome of osmotic demyelination. Hyponatremia must be corrected slowly in order to lessen the chance of the development of Osmotic demyelination syndrome or central pontine myelinolysis (CPM), a severe neurological disease. In fact, overly rapid correction of hyponatremia is the most common cause of that potentially devastating disorder. During treatment of hyponatremia, the serum sodium should not be allowed to rise by more than 8  mmol/l over 24 hours (i.e. 0.33  mmol/l/h rate of rising). In practice, rapid correction of hyponatremia and then CPM is most likely to occur during the treatment of hypovolemic hyponatremia. In particular, once the hypovolemic state has been corrected, the signal for ADH release disappears. At that point, there will be an abrupt water diuresis (since there is no longer any ADH acting to retain the water). A rapid and profound rise in serum sodium can then occur. Should the rate of rising of serum sodium exceed 0.33  mmol/l/h over several hours, vasopressin may be administered to prevent ongoing rapid water diuresis.

Surgery

Primary Prevention

In patients at risk of developing hyponatremia, preventing approaches has to be done to eliminate the aggravation of hyponatremia.

Secondary Prevention

The rate of correction for hyponatremia is very crucial for preventing the complication of treatment like osmotic demyelination syndrome.

References

  1. Greenberg A, Verbalis JG, Amin AN, Burst VR, Chiodo JA, Chiong JR; et al. (2015). "Current treatment practice and outcomes. Report of the hyponatremia registry". Kidney Int. 88 (1): 167–77. doi:10.1038/ki.2015.4. PMC 4490559. PMID 25671764.


Template:WikiDoc Sources